bioAffinity Technologies, Inc.
(BIAF)Financial Statements · SEC EDGAR XBRL
Revenue
$6.2M
-34.2%
Net Income
-$14.9M
-64.9%
EPS
$-8.66
+61.5%
Op. Income
-$10.6M
-18.1%
FCF
-$9.4M
-27.9%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Selling General & Admin
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Interest Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)